Mini reviewPublished 31 Dec 2022
INVESTIGATING DRUG RESPONSE ASSAY'S POTENTIAL FOR PRECISION THERAPY IN OVARIAN CANCER
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Different patient reactions to current standard of care anti-cancer medications are one of the biggest obstacles in the treatment of cancer. Different genetic, epigenomic, proteomic, and metabolic abnormalities across people with the same kind of cancer may contribute to these varied responses. Precision medicine is an emerging method in cancer therapies that takes into consideration distinct genomic abnormalities, environmental factors as well as lifestyle of individual patients. Using the patient's unique tumour features, this method enables clinicians and researchers to choose or forecast the treatments that would most likely benefit the patient. Predictive in vitro drug-response assays that measure the sensitivity of patient tumour cells to standard or experimental treatments are one type of precision medicine tool.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Research and Technology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Whiker Worth”